13:15:17 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-02-20 Bokslutskommuniké 2023
2023-11-07 Kvartalsrapport 2023-Q3
2023-08-18 Kvartalsrapport 2023-Q2
2023-04-26 Ordinarie utdelning BIOS 0.00 SEK
2023-04-25 Årsstämma 2023
2023-04-25 Kvartalsrapport 2023-Q1
2023-02-22 Bokslutskommuniké 2022
2022-11-15 Kvartalsrapport 2022-Q3
2022-09-19 Extra Bolagsstämma 2022
2022-08-31 Kvartalsrapport 2022-Q2
2022-05-04 Ordinarie utdelning BIOS 0.00 SEK
2022-05-03 Kvartalsrapport 2022-Q1
2022-05-03 Årsstämma 2022
2022-02-17 Bokslutskommuniké 2021
2021-11-09 Kvartalsrapport 2021-Q3
2021-08-12 Kvartalsrapport 2021-Q2
2021-05-04 Kvartalsrapport 2021-Q1
2021-04-20 Ordinarie utdelning BIOS 0.00 SEK
2021-04-19 Årsstämma 2021
2021-02-23 Bokslutskommuniké 2020
2020-11-05 Kvartalsrapport 2020-Q3
2020-08-18 Kvartalsrapport 2020-Q2
2020-05-08 Ordinarie utdelning BIOS 0.00 SEK
2020-05-07 Kvartalsrapport 2020-Q1
2020-05-07 Årsstämma 2020
2020-02-21 Bokslutskommuniké 2019
2019-11-05 Kvartalsrapport 2019-Q3
2019-09-10 Extra Bolagsstämma 2019
2019-08-13 Kvartalsrapport 2019-Q2
2019-05-10 Ordinarie utdelning BIOS 0.00 SEK
2019-05-06 Kvartalsrapport 2019-Q1
2019-05-06 Årsstämma 2019
2019-02-19 Bokslutskommuniké 2018
2018-11-06 Kvartalsrapport 2018-Q3
2018-10-02 Extra Bolagsstämma 2018
2018-08-24 Kvartalsrapport 2018-Q2
2018-05-03 Ordinarie utdelning BIOS 0.00 SEK
2018-05-02 Årsstämma 2018
2018-05-02 Kvartalsrapport 2018-Q1
2018-02-26 Bokslutskommuniké 2017
2017-11-16 Kvartalsrapport 2017-Q3
2017-08-17 Kvartalsrapport 2017-Q2

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorIndustri
IndustriIndustriprodukter
Bioservo Technologies är ett teknikbolag inriktade mot hälsovårdssektorn. Bolaget utvecklar robotteknologi anpassat för personer som lider utav nedsatt muskelstyrka. Teknologin baseras på den framtagna SEM-teknologin (Soft Extra Muscle), som används för att hantera patientens uthållighet. Ett exempel är bolagets servohandske som är anpassad för personer med nedsatt funktion i händerna. Bolaget grundades 2006 och har sitt huvudkontor i Kista.
2023-08-29 08:30:00

Bioservo signs a Sales Agent agreement with Trivet Medical LLC for sales of Carbonhand to Hospitals, Clinics, and Medical Centers within the Veterans Health Administration and Department of Defense in the US. With the first Sales Agent in place, the grip-strengthening device Carbonhand is available for all US Veterans suffering from impaired hand function.

[Carbonhand hjlper till i vardagen]

Trivet Medical LLC is a specialized strategic sales and distribution LLC, highly focused on commercializing disruptive, best-in-class med-tech devices and technologies. Founded by Charles Coyle, Trivet Medical's mission is to develop underrepresented and underserved healthcare conditions through innovative technology within the Department of Defense, Veterans Health, and key US Healthcare Markets, Regionally and Nationally. The sales team and channel comprise of successful and seasoned industry executives who have served in sales leadership, sales management & and sales training roles. 

"We are excited and pleased to represent Bioservo for the US launch within the Department of Defense Hospitals and Veteran's Health Institutions", says Charles Coyle, founder of Trivet Medical LLC, and continues, "Carbonhand is a smart, intuitive, and revolutionary aid that gives back power to people with impaired hand function. There is no greater honor than to be of service to a member of our US Armed Forces who has given sacrifice, sustained injury, loss, or hardship.  We are proud to be part of a restorative solution that impacts everyday life for US Veterans."

"Our initial focus in the US is to increase independence and quality of life for US Veterans with impaired hand function. The Veterans Health Administration includes the largest coordinated healthcare system in the United States and has 9 million individuals enrolled, says Petter Bäckgren, CEO, Bioservo Technologies. "Recently we announced the agreement with Veterans Health Solutions Service as a wholesale distributor, the Trivet Medial sales team now signed is the first to start to promote Carbonhand to Veteran's Health Institutions. We will continue to expand our sales channel within the Veterans Health Administration."

For more information, please contact,
Petter Bäckgren, CEO, Bioservo Technologies AB
Phone: +468 21 17 10
petter.backgren@bioservo.com

Loren Wass, US Commercial Development, Bioservo Technologies AB
Phone: +1 978 502 6330
Loren.wass@bioservo.com

About Bioservo Technologies
Bioservo Technologies AB (publ) is a world-leading company in wearable muscle strengthening systems for people in need of extra strength and endurance. All our innovative products and systems are designed to keep people strong, healthy, and efficient. The company has a unique global position within soft exoskeleton technology for the hand, both for industrial applications to improve the health of workers and to improve the quality of life for people with reduced muscle strength. Bioservo Technologies was founded in 2006 in collaboration between researchers at the Royal Institute of Technology and a doctor at Karolinska University Hospital. Bioservo Technologies is a Swedish public limited company with headquarters in Stockholm.
FNCA Sweden AB is the company's Certified Adviser on Nasdaq First North.
For more information, please visit www.bioservo.com